Delivery Order SPE2DB22D3501-SPE2DB25FTN14

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the DUOVISC Viscoelastic System 1.05ML medical product, with a ceiling value of $6,482.18 and a completion date of November 15, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product, with a firm fixed price ceiling value of $10,696.14 and a period of performance through March 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the DUOVISC VISCOELASTIC SYSTEM 1.05ML pharmaceutical product. The contract has a firm fixed price of $10,898.95 and a completion date of November 19, 2024. The order was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary...
This is a $1,302.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the DUOVISC VISCOELASTIC SYSTEM 0.75ML medical product, with a performance period through March 27, 2025. The contract was not set aside for any specific socioeconomic program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product. The contract has a firm fixed price ceiling value of $2,650.10 and a period of performance through February 19, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,627.08 firm fixed-price delivery order is for the DUOVISC Viscoelastic System 1.05ML, a medical product used in various healthcare applications. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the DUOVISC VISCOELASTIC SYSTEM 1.05ML, a medical supply product, with a ceiling value of $2,756.10. The contract is a firm-fixed price delivery order with an ultimate completion date of March 5, 2025. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1.05 mL of the DUOVISC Viscoelastic System, a medical supply product, to support military healthcare programs. The award has a ceiling value of $1,325.05 and runs through August 27, 2024. This delivery order is part of a larger $999,999,999 IDC held by Amerisourcebergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp. The $8,960.10 firm fixed price delivery order is for the procurement of 4,567,011 units of the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,378.05, is for the procurement of the DUOVISC Viscoelastic System 1.05ML medical product. The delivery order is placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTN14
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DUOVISC VISCOELASTIC SYSTEM 1.05ML, a medical product, with a ceiling value of $4,564.51 and a period of performance through November 19, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 5/20/25, 2:09 PM